Autor: "Schultz NH" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis.
Autorzy:: Schultz NH; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Department of Hematology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Holme PA; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Bjørnsen S; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Henriksson CE; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Sandset PM; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Jacobsen EM; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Pokaż więcej
Źródło:: Platelets [Platelets] 2020; Vol. 31 (1), pp. 43-47. Date of Electronic Publication: 2018 Dec 20.
Typ publikacji:: Journal Article
MeSH Terms:: Factor Xa Inhibitors/*pharmacology
Hemostasis/*drug effects
Rivaroxaban/*pharmacology
Venous Thrombosis/*blood
Venous Thrombosis/*drug therapy
Adenosine Triphosphate/metabolism ; Adult ; Aged ; Blood Coagulation/drug effects ; Blood Coagulation Tests ; Blood Platelets/drug effects ; Blood Platelets/metabolism ; Factor Xa Inhibitors/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Platelet Activation ; Platelet Aggregation/drug effects ; Rivaroxaban/therapeutic use ; von Willebrand Factor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
Autorzy:: Schultz NH; Department of Haematology, Oslo University Hospital, Box 4950, N-0424, Oslo, Norway. n.h.schultz@medisin.uio.no.; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, N-0424, Oslo, Norway. n.h.schultz@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Box 1171, Blindern, N-0318, Oslo, Norway. n.h.schultz@medisin.uio.no.; Department of Haematology, Akershus University Hospital, N-1478, Lørenskog, Norway. n.h.schultz@medisin.uio.no.
Lundblad R; Department of Cardiothoracic Surgery, Oslo University Hospital, Box 4950, N-0424, Oslo, Norway.
Holme PA; Department of Haematology, Oslo University Hospital, Box 4950, N-0424, Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, N-0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Box 1171, Blindern, N-0318, Oslo, Norway.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2018 May 16; Vol. 12 (1), pp. 138. Date of Electronic Publication: 2018 May 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Cardiovascular Surgical Procedures*
Factor Xa Inhibitors*
Blood Coagulation/*drug effects
Blood Coagulation Factors/*therapeutic use
Pyrazoles/*antagonists & inhibitors
Pyridones/*antagonists & inhibitors
Aged ; Blood Coagulation Tests ; Emergencies ; Humans ; Male ; Middle Aged ; Thrombelastography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.
Autorzy:: Schultz NH; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Department of Haematology, Akershus University Hospital, N-1478 Lørenskog, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway.
Tran HTT; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Department of Haematology, Akershus University Hospital, N-1478 Lørenskog, Norway.
Bjørnsen S; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.
Henriksson CE; Department of Medical Biochemistry, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.
Sandset PM; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway.
Holme PA; Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway.; Pokaż więcej
Źródło:: Thrombosis journal [Thromb J] 2017 Feb 20; Vol. 15, pp. 6. Date of Electronic Publication: 2017 Feb 20 (Print Publication: 2017).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Schultz NH"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język